GlassScriptPhysician profile
John G Deleonibus
NPI 1366537102
$1,159.45
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $550 · 2021: $48.75.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $707.43 | 2019-2021 | |
| Stryker Corporation | $201.94 | 2019 | |
| Zimmer Biomet Holdings, INC. | $86.60 | 2019 | |
| Paratek Pharmaceuticals, INC. | $65.50 | 2019-2020 | |
| Supreme Orthopedic Systems, LLC | $21.18 | 2019 | |
| Horizon Therapeutics Plc | $18.54 | 2019 | |
| Organogenesis INC. | $17.57 | 2020 | |
| Glenmark Therapeutics INC. | $16.00 | 2019 | |
| Medtronic Vascular, INC. | $13.47 | 2019 | |
| Tei Medical INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Deleonibus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.